WED, AUGUST, 2, 1995
ROOM
A
SESSION 15:
9:00 State
Of The Art
Chairperson: Dr.
S. Kabalan
Blood pressure and
microalbuininuria in diabetes: prevalence, pathogenesis, and
management
Dr. C. Mogensen
SESSION
16:
Diabetes,
Hypertension And Insulin Resistance
Chairpersons: Drs.
Z. Eumadand E. Hajjar
10:00 Hypertension
and renal disease in non insulin dependent diabetes mellitus
Dr. N Ismall
10:20 Insulin resistance
in hypertension: mechanisms, prognostic significance and treatment
Dr. H. Lithell
10:40 Insulin resistance
in genetic and secondary experimental hypertension
Drs. R. Hamdan, A.
Birbari andA. Jurjus
11:00 Hyperinsulinemia
and hypertension: a causal relation or a mere association
Dr. O. Abdel Aziz
11:20 Evaluation of
relation between hyperinsulinemia, apolipoproteins level and
other risk tactors in essential hypertension
Drs. A. Doina andA.
Ivan
SESSION
17:
11:45 State
Of The Art
Chairperson: Dr.
J. Semaan
Experimental approaches
to determining choice for first step drug therapy of patients
with hypertension
Dr. P. Whelton
SESSION
19:
14:00 State
Of The Art
Chairperson: Dr.
M ElNouzha
Is gehypertension
a systemic disorder or a single hemodynamic abnormality
Drs. A. Birbari, A.
Jurjus, F. Saleh andL Sharaf
ROOM
A
SESSION 20:
15:00 State
Of The Art
Chairperson: Dr.
A. Mousalli
Hypertension and the
kidney: magnitude of risk and therapeutic response
Dr. P. Whefton
SESSION
21:
16:00 State
Of The Art
Chairperson: Dr.
N ElAdem
Does exercise lower
blood pressure, if so, how?
Dr. K. Arakawa
17:00
SATELLITE
SYMPOSIUM
Chairpersons: Drs.
S. Alam andA. Birbari
A
New Standard For Cardiac Care: Treatment Of The
Post-MI Patient
Role of ACE in
management of post myocardial
infraction
Dr. W H. Van Gilst
Prevention of coronary
heart disease and implications of cholesterol reducing therapy
Dr. D. W
Erkelens
Cost-effectiveness
of cardiovascular drugs
Dr. D. Harron
MSD
ROOM
B
SESSION 18:
Hypertension
And The Kidney
Chairpersons: Drs.
G. Frem and J. Kassouf
10:00 Morphological
renal hypertensive changes
Dr. G. Aftimos
10:15 Renal flinction
in hypertension
Dr. A. Mimran
10:35 Glomerular hypertension
and progression of renal disease
Dr. K. Badr
10:55 Ischemic nephropathy
Dr. N Ismall
11:15 The contribution
of hypertension to dialysis patients outcome
Dr. N Ismall
